Director · Immuneering Corp · Class A Common Stock
Side
BUY
Value
$101K
Shares
21.6K
Price
$4.67
Executed
Jan 15, 2026
Disclosed
Jan 20, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Jan 15 executedJan 20, 2026 disclosed
IMRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
4 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Schall Thomas J. filed this Form 4 reporting a open-market purchase of IMRX on Jan 15, 2026. It became public on Jan 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Schall Thomas J.cik:0001423084
Issuer
Immuneering Corpcik:0001790340
Revision history · 0
No field has changed since this record was first ingested.
